{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:49:58Z","timestamp":1783050598590,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374262"],"award-info":[{"award-number":["82374262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305010"],"award-info":[{"award-number":["82305010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bioorg.2025.108326","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:11:38Z","timestamp":1741000298000},"page":"108326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Discovery of ASGR1 and HMGCR dual-target inhibitors based on supervised learning, molecular docking, molecular dynamics simulations, and biological evaluation"],"prefix":"10.1016","volume":"158","author":[{"given":"Yanfeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangjin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108326_bb0005","article-title":"There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: a review of current practice and recommendations for improved effectiveness. American journal of","author":"Makover","year":"2022","journal-title":"Prev Cardiol"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108326_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpha.2023.05.010","article-title":"Novel wine in an old bottle: preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases","volume":"13","author":"Gou","year":"2023","journal-title":"J Pharmaceutical Anal"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108326_bb0015","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108326_bb0020","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1161\/ATVBAHA.116.307993","article-title":"Atherosclerotic plaque rupture: identifying the straw that breaks the Camel\u2019s back","volume":"36","author":"Chen","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108326_bb0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/eurheartj\/ehab600","article-title":"Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis","volume":"43","author":"DeFilippis","year":"2022","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.bioorg.2025.108326_bb0030","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108326_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028892","article-title":"Evolving management of low-density lipoprotein cholesterol: a personalized approach to preventing atherosclerotic cardiovascular disease across the risk continuum","volume":"12","author":"Wilkinson","year":"2023","journal-title":"JAHA"},{"issue":"16","key":"10.1016\/j.bioorg.2025.108326_bb0040","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCULATIONAHA.123.064041","article-title":"How low can you go? New evidence supports no lower bound to low-density lipoprotein cholesterol level in secondary prevention","volume":"147","author":"Rodriguez","year":"2023","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108326_bb0045","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41569-023-00860-8","article-title":"Novel and future lipid-modulating therapies for the prevention of cardiovascular disease","volume":"20","author":"Brandts","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.bioorg.2025.108326_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2017.05.018","article-title":"Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: a real-world evidence study in primary care","volume":"263","author":"Guglielmi","year":"2017","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108326_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/clc.23935","article-title":"Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease","volume":"46","author":"Desai","year":"2023","journal-title":"Clin Cardiol"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108326_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/MAJ.0000000000000292","article-title":"Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease","volume":"348","author":"Gamboa","year":"2014","journal-title":"Am J Med Sci"},{"issue":"17","key":"10.1016\/j.bioorg.2025.108326_bb0065","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy\u2014European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108326_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/FJC.0000000000001386","article-title":"Significance of statin-associated muscle symptoms and its impact on patients adherence and outcomes","volume":"81","author":"Al-Makhamreh","year":"2023","journal-title":"J Cardiovasc Pharmacol"},{"issue":"26","key":"10.1016\/j.bioorg.2025.108326_bb0075","doi-asserted-by":"crossref","first-page":"18707","DOI":"10.1074\/jbc.R113.479808","article-title":"Controlling cholesterol synthesis beyond 3-Hydroxy-3-methylglutaryl-CoA reductase (HMGCR)","volume":"288","author":"Sharpe","year":"2013","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.bioorg.2025.108326_bb0080","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.3390\/molecules25173891","article-title":"An atomic-level perspective of HMG-CoA-reductase: the target enzyme to treat hypercholesterolemia","volume":"25","author":"Gesto","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108326_bb0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrd1112","article-title":"Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors","volume":"2","author":"Tobert","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"34","key":"10.1016\/j.bioorg.2025.108326_bb0090","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","article-title":"Prevalence of statin intolerance: a meta-analysis","volume":"43","author":"Byty\u00e7i","year":"2022","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108326_bb0095","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2016.12.036","article-title":"Statin intolerance and risk of coronary heart events and all-cause mortality following myocardial infarction","volume":"69","author":"Serban","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.bioorg.2025.108326_bb0100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.93908","article-title":"Targeted protein degradation systems to enhance Wnt signaling","volume":"13","author":"Sampathkumar","year":"2024","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108326_bb0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MOL.0000000000000395","article-title":"Asialoglycoprotein receptors as important mediators of plasma lipids and atherosclerosis","volume":"28","author":"Igdoura","year":"2017","journal-title":"Curr Opin Lipidol"},{"issue":"22","key":"10.1016\/j.bioorg.2025.108326_bb0110","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa1508419","article-title":"Variant ASGR1 associated with a reduced risk of coronary artery disease","volume":"374","author":"Nioi","year":"2016","journal-title":"N Engl J Med"},{"issue":"7922","key":"10.1016\/j.bioorg.2025.108326_bb0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-022-05006-3","article-title":"Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.bioorg.2025.108326_bb0120","first-page":"5","article-title":"Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison","volume":"11","author":"Shen","year":"2023","journal-title":"J Chemother"},{"issue":"D1","key":"10.1016\/j.bioorg.2025.108326_bb0125","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bioorg.2025.108326_bb0130","article-title":"Attention is all you need","volume":"30","author":"Vaswani","year":"2017","journal-title":"Adv Neural Inf Process Syst"},{"issue":"5519","key":"10.1016\/j.bioorg.2025.108326_bb0135","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.bioorg.2025.108326_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002997","article-title":"Triantennary galNAc molecular imaging probes for monitoring hepatocyte function in a rat model of nonalcoholic steatohepatitis","volume":"7","author":"Mishra","year":"2020","journal-title":"Adv Sci"},{"key":"10.1016\/j.bioorg.2025.108326_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108326_bb0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE - anteChamber python parser interface","volume":"5","author":"Sousa Da Silva","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.bioorg.2025.108326_bb0155","doi-asserted-by":"crossref","unstructured":"Kagami L, Wilter A, Diaz A, Vranken W. The ACPYPE web server for small-molecule MD topology generation. Elofsson A, editor. Bioinformatics. 2023 Jun 1;39(6):btad350.","DOI":"10.1093\/bioinformatics\/btad350"},{"issue":"14","key":"10.1016\/j.bioorg.2025.108326_bb0160","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J Med Chem"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825002068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825002068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T18:32:29Z","timestamp":1765218749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825002068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"alternative-id":["S0045206825002068"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108326","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of ASGR1 and HMGCR dual-target inhibitors based on supervised learning, molecular docking, molecular dynamics simulations, and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108326"}}